Submitted:
18 January 2024
Posted:
19 January 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Data source
2.2. Study population and design
2.3. Data collection
2.4. Statistical analysis
3. Results
3.1. Baseline Characteristics of the Subjects Included
3.2. Vp Correlation with Left Ventricular Diastolic Function Parameters
| Independent Variables | Vp | |
| ρ | ρ | |
| E/E' | –0.379 | 0.029 |
| MV E vel | 0.226 | 0.206 |
| E/A | 0.213 | 0.234 |
| Sept E' | 0.636 | < 0.001 |
| Lat E' | 0.650 | < 0.001 |
| TR Vmax | –0.079 | 0.663 |
| LAVI | –0.231 | 0.195 |
3.3. The Echocardiographic Parameter Correlation Test Results with The Degree of Diastolic Dysfunction
3.4. Correlation of Estimated PCWP Based on E/Vp Ratio with NT–ProBNP
4. Discussion
4.1. Vp Correlation with Left Ventricular Diastolic Function Parameters
4.2. Vp Correlation with Left Ventricular Diastolic Dysfunction Degree
4.3. Correlation of Estimated PCWP Based on E/Vp Ratio with NT–ProBNP
4.4. Study Limitation
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599–726. [CrossRef]
- Naing P, Forrester D, Kangaharan N, Muthumala A, Mon Myint S, Playford D. Heart failure with preserved ejection fraction: A growing global epidemic. Aust J Gen Pract 2019;48:465–71. [CrossRef]
- Marco Tubaro, Pascal Vranckx SP, Vrints and C. Acute heart failure: Epidemiology, classification, andpathophysiology. ESC Textb. Intensive AcuteCardiovascular Care (2 ed.). 2 ed, Oxford: Oxford University Press; 2018. [CrossRef]
- Pfeffer MA, Shah AM, Borlaug BA. Heart Failure With Preserved Ejection Fraction In Perspective. Circ Res 2019;124:1598–617. [CrossRef]
- Kossaify A, Nasr M. Diastolic Dysfunction and the New Recommendations for Echocardiographic Assessment of Left Ventricular Diastolic Function: Summary of Guidelines and Novelties in Diagnosis and Grading. J Diagnostic Med Sonogr 2019;35:317–25. [CrossRef]
- Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr 2016;29:277–314. [CrossRef]
- Singh A, Mehta Y. Heart failure with preserved ejection fraction (HFpEF): Implications for the anesthesiologists. J Anaesthesiol Clin Pharmacol 2018;34:161–5. [CrossRef]
- Ravi Vishnu Prasad1, Kumar Vikram Singh1, K. K. Sethi2 SS. Role of Flow Propagation Velocity Across Mitral Valve in the Assessment of Diastolic Dysfunction and Prognostication in Acute Myocardial Infarction. J Indian Acad Echocardiogr Cardiovasc Imaging 2020;4:11-7. [CrossRef]
- IBM Corp. IBM SPSS Statistics for Windows 2017.
- SHAPIRO SS, WILK MB. An analysis of variance test for normality (complete samples). Biometrika 1965;52:591–611. [CrossRef]
- Spearman Rank Correlation Coefficient BT - The Concise Encyclopedia of Statistics, New York, NY: Springer New York; 2008, p. 502–5. [CrossRef]
- Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr 2009;22:107–33. [CrossRef]
- Maeder MT, Buser M, Brenner R, Rickli H. [Heart failure with preserved ejection fraction (HFpEF)]. Ther Umsch 2018;75:161–9. [CrossRef]
- Solomon SD, McMurray JJ V, Anand IS, Ge J, Lam CSP, Maggioni AP, et al. Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. N Engl J Med 2019;381:1609–20. [CrossRef]
- Otterstad JE. Measuring left ventricular volume and ejection fraction with the biplane Simpson’s method. Heart 2002;88:559–60. [CrossRef]
- Hodzic A, Bonnefous O, Langet H, Hamiche W, Chaufourier L, Tournoux F, et al. Analysis of inter-system variability of systolic and diastolic intraventricular pressure gradients derived from color Doppler M-mode echocardiography. Sci Rep 2020;10:7180. [CrossRef]
- Nagueh SF. Diastology: 2020-A practical guide. Echocardiography 2020;37:1919–25. [CrossRef]
- Stewart KC, Kumar R, Charonko JJ, Ohara T, Vlachos PP, Little WC. Evaluation of LV diastolic function from color M-mode echocardiography. JACC Cardiovasc Imaging 2011;4:37–46. [CrossRef]
- Bavry AA, Anderson RD, Gong Y, Denardo SJ, Cooper-Dehoff RM, Handberg EM, et al. Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy. Hypertens (Dallas, Tex 1979) 2010;55:48–53. [CrossRef]
- Andersen OS, Smiseth OA, Dokainish H, Abudiab MM, Schutt RC, Kumar A, et al. Estimating Left Ventricular Filling Pressure by Echocardiography. J Am Coll Cardiol 2017;69:1937–48. [CrossRef]
- Januzzi JLJ, Chen-Tournoux AA, Christenson RH, Doros G, Hollander JE, Levy PD, et al. N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study. J Am Coll Cardiol 2018;71:1191–200. [CrossRef]
- Sugimoto T, Dohi K, Tanabe M, Watanabe K, Sugiura E, Nakamori S, et al. Echocardiographic estimation of pulmonary capillary wedge pressure using the combination of diastolic annular and mitral inflow velocities. J Echocardiogr 2013;11:1–8. [CrossRef]
- Kidawa M, Coignard L, Drobinski G, Krzeminska-Pakula M, Thomas D, Komajda M, et al. Comparative value of tissue Doppler imaging and m-mode color Doppler mitral flow propagation velocity for the evaluation of left ventricular filling pressure. Chest 2005;128:2544–50. [CrossRef]
- Kawase Y, Kawasaki M, Tanaka R, Nomura N, Fujii Y, Ogawa K, et al. Noninvasive estimation of pulmonary capillary wedge pressure in patients with mitral regurgitation: A speckle tracking echocardiography study. J Cardiol 2016;67:192–8. [CrossRef]


| Study Subject Characteristics |
Study Subjects= 33 (%, mean ± SD) |
| Age | 53.55 ± 16.64 |
| Sex | |
| Male | 16 (48.5%) |
| Female | 17 (51.5%) |
| Body Mass Index (BMI) | 26.44 ± 5.1 |
| Blood pressure | |
| Systolic | 135.0 ± 24.69 |
| Diastolic | 84.42 ± 12.01 |
| Comorbidities | |
| Hypertension | 15 (45.5%) |
| Old Myocardial Infarction (OMI) | 8 (24.2%) |
| Acute Coronary Syndrome (ACS) | 9 (27.3 %) |
| Diabetes Mellitus Type 2 | 6 (18.2%) |
| Chronic Kidney Disease (CKD) | 3 (9.1%) |
| Preeclampsia | 2 (6.1%) |
| Chronic Obstructive Pulmonary Disease (COPD) | 1 (3%) |
| The Degree of Diastolic Dysfunction | |
| Grade I | 26 (78.8%) |
| Grade II | 4 (12.1%) |
| Grade III | 3 (9.1%) |
| Study Parameters | Value / Mean ± SD Median (Range) |
| EF | 54% (50 – 68%) |
| LVIDD | 4.93 cm ± 0.586 cm |
| E vel | 64 cm/s (34 – 132 cm/s) |
| E/A ratio | 0.79 (0.4 – 2.73) |
| Sept E' | 6.64 cm/s ± 1.997 cm/s |
| Lat E' | 8.55 cm/s ± 2.514 cm/s |
| E/E' ratio | 8.5 (5.2 – 24) |
| TR Vmax | 0 m/s (0 – 3.4 m/s) |
| LAVI | 25.5455 ml/m2 ± 6.64904 ml/m2 |
| Vp | 35 cm/s (20 – 48 cm/s) |
| E/Vp ratio | 2.01 (1.02 – 3.85) |
| Estimated PCWP E/Vp | 13.8 mm Hg (10.4 – 27.7 mm Hg) |
| Estimated PCWP E/E' | 12.4 mm Hg (9.3 – 31.6 mm Hg) |
| NT–ProBNP | 1868 pg/ml (95.3 – 35000 pg/ml) |
| Parameter | Category | Frequency | Mean (SD) | Median (Range) | Correlation |
| VP | Grade I | 26 (78.8) | 35.88 ± 7.916 | 39.50 (20 – 48) | 0.165 (0.360) |
| Grade II | 4 (12.1) | 30.50 ± 8.544 | 28.00 (24 – 42) | ||
| Grade III | 3 (9.1) | 33.33 ± 7.572 | 30.00 (28 – 42) | ||
| PCWP E/Vp | Grade I | 26 (78.8) | 14.227 ± 2.280 | 13.50 (10.40 – 0.20) | 0.478 (0.005) |
| Grade II | 4 (12.1) | 18.125 ± 4.828 | 18.00 (13.10 – 23.40) | ||
| Grade III | 3 (9.1) | 19.967 ± 6.842 | 17.50 (14.70 – 27.70) | ||
| PCWP E/E' | Grade I | 26 (78.8) | 12.469 ± 2.778 | 11.6 (9.30 – 20.80) | 0.427 (0.013) |
| Grade II | 4 (12.1) | 14.175 ± 1.223 | 13.65 (13.40 – 16.00) | ||
| Grade III | 3 (9.1) | 19.133 ± 10.804 | 13.30 (12.50 – 31.60) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).